Variable | Number of patients | 5-year survival rate | Median survival (months) | P-value |
---|---|---|---|---|
Age (years) | 0.939 | |||
≤ 60 | 87 | 51% | 63 | |
> 60 | 48 | 52% | 61 | |
Sex | 0.500 | |||
Female | 26 | 48% | 63 | |
Male | 169 | 52% | 60 | |
Tumor length | 0.903 | |||
≤ 5 cm | 100 | 51% | 63 | |
> 5 cm | 35 | 50% | 88 | |
Differentiation | 0.553 | |||
G1 | 38 | 59% | 74 | |
G2 | 81 | 48% | 59 | |
G3 | 16 | 49% | 60 | |
T category | 0.041 | |||
T1 | 30 | 67% | 86 | |
T2 | 26 | 55% | 77 | |
T3 | 79 | 44% | 45 | |
Intramural metastasis | 0.135 | |||
No | 131 | 52% | 63 | |
Yes | 4 | 25% | 29 | |
Number of dissected lymph nodes | ||||
≤ 25 | 77 | 53% | 66 | 0.929 |
> 25 | 58 | 48% | 60 | |
Lymphadenectomy | 0.206 | |||
2-field | 110 | 48% | 60 | |
3-field | 25 | 66% | 87 | |
N | ||||
Negative | 102 | 58% | 74 | 0.008 |
Positive | 33 | 32% | 34 |